Cocrystal Pharma Inc. Stock
Your prediction
Cocrystal Pharma Inc. Stock
Cocrystal Pharma Inc. gained 0.510% compared to yesterday.
Our community identified positive and negative aspects for Cocrystal Pharma Inc. stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the Cocrystal Pharma Inc. stock. On the other hand our users think that "Innovation" could be a problem in the future.
Pros and Cons of Cocrystal Pharma Inc. in the next few years
Pros
?
B****
?
M***** P*******
?
S********** s********
Cons
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Cocrystal Pharma Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Cocrystal Pharma Inc. | 0.510% | 2.674% | 18.519% | -25.000% | 17.791% | -61.600% | -90.643% |
| Pacira Pharmaceuticals | 0.000% | 4.000% | -6.306% | -1.887% | -3.704% | -37.349% | -56.118% |
| Corcept Therapeutics Inc. | -0.390% | 8.066% | 29.270% | 71.518% | 51.653% | 262.587% | 489.205% |
| Supernus Pharmaceuticals | -0.490% | 1.471% | 0.000% | 13.115% | -3.721% | 48.921% | 100.971% |
Comments
Cocrystal Pharma, Inc. (NASDAQ: COCP) had its price target lowered by analysts at HC Wainwright from $7.00 to $6.00. They now have a "buy" rating on the stock.
Show more
Ratings data for COCP provided by MarketBeat
Cocrystal Pharma, Inc. (NASDAQ: COCP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
Show more
Ratings data for COCP provided by MarketBeat
Cocrystal Pharma, Inc. (NASDAQ: COCP) had its price target lowered by analysts at HC Wainwright from $10.00 to $7.00. They now have a "buy" rating on the stock.
Show more
Ratings data for COCP provided by MarketBeat